Mapping Exposure-Induced Immune Effects: Connecting the Exposome and the Immunome
Immune-mediated, non-communicable diseases, such as autoimmune diseases, allergic diseases and asthma, are chronic disorders in which the immune system plays a pivotal role. The World Health Organisation (WHO) has highlighted the seriousness of autoimmunity and its association with exposure to the environment.
EXIMIOUS aims to deliver a new way of assessing the human exposome, i.e. the exposures to environmental factors that one experiences throughout life, and shed light on its association to immune-mediated diseases.
Don’t know what the exposome is?
Want to know more about exposure-related immune diseases?
Curious to know more about what to expect from this project?
EXIMIOUS is a 5 year Research and Innovation Action funded by the European Union’s Horizon 2020 programme.
This month we’re pleased to introduce accelopment Schweiz AG, our EXIMIOUS partner in the lead for the project’s communication, dissemination and exploitation . Based in Zürich, Switzerland, accelopment has been a sparring partner in the acquisition, management and communication and dissemination support of EU funded projects for research and innovation since 2008.
Mapping Exposure-Induced Immune Effects: Connecting the Exposome and the Immunome Watch the EXIMIOUS-EPHOR Joint Symposium at IOHA 2021 16 November 2021 You can now rewatch the symposium titled ‘Exposure assessment in the exposome context – need for precise – broad-scope – external exposure assessment’, which was held at the IOHA 2021 international conference (11-15 September
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 874707.